David Stack, Pacira CEO

Af­ter buy­ing out Flex­ion for $450M, Paci­ra qui­et­ly lays off 110 of its em­ploy­ees

Af­ter be­ing ac­quired by Paci­ra Bio­sciences in a $450 mil­lion deal, it looks like Flex­ion Ther­a­peu­tics qui­et­ly brought out the axe.

While de­tails re­main few and short, here’s what we know: The com­pa­ny re­port­ed a lay­off to Mass­a­chu­setts as part of the state’s Work­er Ad­just­ment and Re­tain­ing Act (WARN) — some­thing com­pa­nies are oblig­ed to do when there are im­pend­ing lay­offs — and list­ed in last week’s re­port. Ac­cord­ing to the re­port, 110 em­ploy­ees had been shown the door. The com­pa­ny list­ed the lay­off date as Jan. 18 with no cor­po­rate an­nounce­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.